Target and Its Patented Drug(s)

Content Navigation (  All   None )                                      
Target General Information
Patent(s) and the Corresponding Patented Drug(s)
References
Target General Information  Top
Target ID T57700 Target Info
Target Name Tyrosine-protein kinase Kit (KIT)
Synonyms v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; p145 c-kit; Proto-oncogene tyrosine-protein kinase Kit; Proto-oncogene c-Kit; Piebald trait protein; PBT; Mast/stem cell growth factor receptor Kit; CD117 antigen; CD117; C-kit
Target Type Successful Target
Gene Name KIT
Biochemical Class Kinase
UniProt ID
KIT_HUMAN
Patent(s) and the Corresponding Patented Drug(s)  Top
United States Patent and Trademark Office (USPTO)
Patent ID US9029386
Title Inhibitors of Kinase Activity.
Applicant(s) Ym Biosciences Australia Pty
Representative Drug(s) D0AK1F Drug Info N.A. Click to Show More [1]
2 D0NB1V Drug Info N.A. [1]
3 D0O0AW Drug Info N.A. [1]
4 D0O4TA Drug Info N.A. [1]
5 D0T7BE Drug Info N.A. [1]
Patent ID US20130137660
Title Inhibitors of Kinase Activity.
Applicant(s) Ym Biosciences Australia Pty
Representative Drug(s) D0AK1F Drug Info N.A. Click to Show More [1]
2 D0NB1V Drug Info N.A. [1]
3 D0O0AW Drug Info N.A. [1]
4 D0O4TA Drug Info N.A. [1]
5 D0T7BE Drug Info N.A. [1]
References  Top
REF 1 RET kinase inhibitors: a review of recent patents (2012-2015).Expert Opin Ther Pat. 2017 Jan;27(1):91-99.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.